Neuberger High Yield Strategies Fund Inc. reports fund developments for a closed-end management investment company focused on high total return through income and capital appreciation. Under normal market conditions, the Fund invests at least 80% of total assets in below-investment-grade debt securities of U.S. and foreign issuers, with capacity for other securities, financial instruments and collateralized loan obligations.
Recurring news for NHS centers on monthly common-stock distributions under its level distribution policy, the income and expense factors that affect those distributions, and capital actions such as transferable rights offerings. Updates also reference NAV-based pricing mechanics, leverage costs, fund fees and the role of Neuberger Berman Investment Advisers LLC as investment adviser.
Neuberger High Yield Strategies Fund (NHS) declared a monthly distribution of $0.0905 per common share, payable November 30, 2026. The record date and ex-date are both November 16, 2026. Under its level distribution policy, the Fund anticipates regular monthly payments at this amount, subject to market conditions, unless further action determines another amount.
Neuberger High Yield Strategies Fund (NHS) declared a monthly distribution of $0.0905 per common share, payable on October 30, 2026.
The record date and ex-date are October 15, 2026. The Fund anticipates regular monthly distributions at this amount, subject to market conditions. Distributions may include investment income, realized capital gains and return of capital.
Neuberger High Yield Strategies Fund (NYSE American: NHS) declared a monthly distribution of $0.0905 per common share, payable on September 30, 2026, to shareholders of record on September 15, 2026 (ex-date also September 15). Under its level distribution policy, the Fund currently anticipates continuing regular monthly distributions of $0.0905 per share, subject to market conditions and future board action.
The Fund notes that maintaining this rate depends on portfolio income, leverage costs and expenses, and that distributions may include net investment income, net realized capital gains and return of capital. Any distribution not consisting solely of net investment income will be accompanied by a Section 19 notice.
High Yield Strategies Fund (NYSE American: NHS) announced Board approval to increase leverage through two actions: a $25 million boost to its committed revolving debt financing and issuance of $10 million in additional Series D Mandatory Redeemable Preferred Shares, both subject to documentation and customary closing conditions.
After completion, the Fund expects up to $135 million in revolving debt capacity and $50 million of Series D Preferred outstanding, aligning total available leverage more closely with its current asset level following a recent transferable rights offering.
Neuberger High Yield Strategies Fund (NYSE American: NHS) declared a monthly distribution of $0.0905 per common share, payable on August 31, 2026 to shareholders of record on August 17, 2026 (ex-date August 17, 2026).
The Fund follows a level distribution policy targeting regular monthly payouts of $0.0905 per share, subject to market conditions. Distributions may include net investment income, net realized capital gains and/or return of capital, with final 2026 tax character determined after year-end.
Neuberger High Yield Strategies Fund (NYSE American:NHS) declared a monthly distribution of $0.0905 per share of common stock. The distribution is payable on July 31, 2026 to shareholders of record on July 15, 2026 (ex-date July 15, 2026).
According to the Fund, it intends, subject to market conditions, to make regular monthly distributions of $0.0905 per share under its level distribution policy, though the rate is not assured and may include net investment income, capital gains and return of capital.
Neuberger High Yield Strategies Fund (NYSE American:NHS) declared a monthly distribution of $0.0905 per share of common stock. The distribution is payable on May 29, 2026, with a record date and ex-date of June 15, 2026.
The Fund expects, subject to market conditions, to continue regular monthly distributions at this rate under its level distribution policy. Distributions may include net investment income, net realized capital gains and return of capital, with final 2026 tax character determined after year-end.
Neuberger High Yield Strategies Fund (NYSE American: NHS) declared a monthly distribution of $0.0905 per common share, payable May 29, 2026, with record and ex-date of May 15, 2026. Under its level distribution policy, the Fund expects to target monthly payments of $0.0905, subject to market conditions and available income.
The Fund cautions that distributions may include net investment income, net realized capital gains, and return of capital; final tax characterization for 2026 will be determined after year-end.
Neuberger High Yield Strategies Fund (NYSE American: NHS) announced final results of its transferable rights offering, which expired April 15, 2026. The final subscription price was $6.50 per share, equal to 92.5% of NAV at the close on the expiration date.
The Offer was over-subscribed and will result in issuance of 10,463,948 shares for gross proceeds of approximately $68.0 million. Subscribed shares are expected to be issued on or about April 21, 2026, with excess payments returned to subscribers. Over-subscription allocations will be made pro-rata to record-date stockholders who submitted requests.
Neuberger High Yield Strategies Fund (NYSE American: NHS) announced preliminary results of its transferable rights offering that ran March 23, 2026–April 15, 2026. The final subscription price was $6.50 per share, equal to 92.5% of NAV at the close on the expiration date.
The Offer was over-subscribed and is expected to issue approximately 10,463,948 shares, generating about $68.0 million gross proceeds. Shares will be issued after pro rata allocation and receipt of payments; final results will be announced later.